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Abstract
Background: Annually over 520,000 newborns die from neonatal sepsis, and 60,000 more from tetanus. Estimates
of the effect of clean birth and postnatal care practices are required for evidence-based program planning.
Objective: To review the evidence for clean birth and postnatal care practices and estimate the effect on neonatal
mortality from sepsis and tetanus for the Lives Saved Tool (LiST).
Methods: We conducted a systematic review of multiple databases. Data were abstracted into standard tables and
assessed by GRADE criteria. Where appropriate, meta-analyses were undertaken. For interventions with low quality
evidence but a strong GRADE recommendation, a Delphi process was conducted.
Results: Low quality evidence supports a reduction in all-cause neonatal mortality (19% (95% c.i. 1–34%)), cord
infection (30% (95% c.i. 20–39%)) and neonatal tetanus (49% (95% c.i. 35–62%)) with birth attendant handwashing.
Very low quality evidence supports a reduction in neonatal tetanus mortality with a clean birth surface (93% (95% c.i.
77-100%)) and no relationship between a clean perineum and tetanus. Low quality evidence supports a reduction of
neonatal tetanus with facility birth (68% (95% c.i. 47-88%). No relationship was found between birth place and cord
infections or sepsis mortality. For postnatal clean practices, all-cause mortality is reduced with chlorhexidine cord
applications in the first 24 hours of life (34% (95% c.i. 5–54%, moderate quality evidence) and antimicrobial cord
applications (63% (95% c.i. 41–86%, low quality evidence). One study of postnatal maternal handwashing reported
reductions in all-cause mortality (44% (95% c.i. 18–62%)) and cord infection ((24% (95% c.i. 5-40%)).
Given the low quality of evidence, a Delphi expert opinion process was undertaken. Thirty experts reached
consensus regarding reduction of neonatal sepsis deaths by clean birth practices at home (15% (IQR 10–20)) or in
a facility (27% IQR 24–36)), and by clean postnatal care practices (40% (IQR 25–50)). The panel estimated that
neonatal tetanus mortality was reduced by clean birth practices at home (30% (IQR(20–30)), or in a facility (38%
(IQR 34–40)), and by clean postnatal care practices (40% (IQR 30–50)).
Conclusion: According to expert opinion, clean birth and particularly postnatal care practices are effective in
reducing neonatal mortality from sepsis and tetanus. Further research is required regarding optimal
implementation strategies.
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More than half a million newborns are estimated to die
each year from serious neonatal infections, accounting
for about 15% of all neonatal deaths globally [1]. The
most vulnerable time for both the mother and newborn
is during birth and in the hours and days immediately
after childbirth. Around 75 percent of neonatal deaths
occur during the first week of life, with the majority in
the first 48 hours [2], which is also the period of highest
risk for mothers [3]. In populations with very high neo-
natal mortality, up to half of neonatal deaths may have
an infectious cause [4,5].
It is estimated that 30-40% of infections resulting in
neonatal sepsis deaths are transmitted at the time of
childbirth and have early onset of symptoms (developing
during the first 72 hours after birth) [6,7]. In low
income countries, about 60% of births occur without a
skilled attendant, most of these at home [8]. Worldwide,
60 million births happen outside facilities and even for
facility births hygienic practices may be sub-optimal.
In addition many neonatal deaths due to tetanus and
other infections are acquired postnatally [9,10]. The
unhealed umbilical cord is an important portal for local
and invasive infections during this period and is rapidly
colonised by bacteria from the maternal genital tract
and then from the environment. Localised umbilical
infection (omphalitis) can spread to the abdominal wall,
the peritoneum, or through the umbilical or portal ves-
sels leading to systemic sepsis, which, if untreated, has a
high case-fatality rate [11]. Omphalitis with redness
extending to the abdominal wall was associated with a
46% increased risk of mortality in rural Nepal [12].
The global burden of neonatal tetanus has reduced
over from over 600,000 neonatal deaths in 1990 to fewer
than 60,000 in 2008 [1,13]. Increased tetanus toxoid vac-
cination coverage and hygienic intrapartum and postnatal
practices, particularly cord care, are important contribut-
ing factors [14,15]. In addition to variation in immuniza-
tion coverage, intrapartum and postnatal practices may
explain much of the local variation in incidence of teta-
nus [16-18]. Clean birth practices have been associated
with dramatic reductions in the incidence of neonatal
tetanus in the absence of immunization, for example in
industrialized countries where tetanus was virtually elimi-
nated before the vaccine was introduced and. in China,
training of traditional birth attendants (TBAs) and pro-
viding them with a ‘clean birth kit’ in the 1950s led to a
reduction in neonatal tetanus rates from 32/1000 in 1948
to 2/1000 in 1961 [19].
Hygienic behaviours during childbirth and during the
early postnatal period are variably defined. In this paper,
we define clean birth and postnatal care practices in
accordance with World Health Organisation’s( W H O )
“six cleans” - hand washing of birth attendant before
birth, clean birth surface, clean perineum, cutting of the
umbilical cord using a clean implement, clean cord tie,
and a clean cloth for drying (Figure 1). These practices
m a yb ei n f l u e n c e db yan u m b e ro fp r o g r a m m a t i c
Figure 1 Conceptual framework of potential role of implementation mechanisms, including kits on clean practices at birth and effects on
neonatal and maternal outcomes.
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tions, commodity provision, or training of attendants, or
combinations of these, and the context may involve a
facility birth or a home birth. Hand-washing with soap
results in a large reduction in hand contamination, even
when washed with unclean water [20], and birth atten-
dant and maternal hand washing have been associated
with reductions in neonatal mortality [21]. However cul-
tural factors frequently govern practices and may influ-
ence willingness to adopt new clean practices [22-24].
Many populations commonly rub potentially harmful
substances on the umbilical cord or skin despite WHO
recommendations for dry cord care [11,25-29]. Chlor-
hexidine, a broad-spectrum topical antiseptic, has resi-
dual effect for up to 72 hours and may be a useful
adjunct to basic clean practices in home and facility set-
tings, especially where unhygienic applications to the
cord are common.
Although such hygienic practices at birth and during
the postnatal period are accepted as a standard of care,
there is very limited evidence regarding their effect to
guide policymakers in the potential mortality effect size.
Individually randomized trials of hygienic versus unhy-
gienic practices would clearly be unethical, and thus the
quality of evidence will always be limited. There is
increasing evidence from cluster randomized trials in
South Asia of the significant effect on neonatal mortality
of postnatal care practices, including clean practices,
[26,30-35]. However all these studies involve packages
with varying intervention content, often with antenatal
and intrapartum care, and in several cases also providing
curative care for infections at home in the postnatal per-
iod. The relative importance and contribution of each
component is difficult to determine. An additional chal-
lenge is that evaluations often consider intermediate
outcomes such as sepsis morbidity or omphalitis, which
are variably defined.
This review does not include other interventions to
reduce deaths from neonatal infections, such as tetanus
toxoid immunization [15], antibiotics for prolonged rup-
ture of membranes, early and/or exclusive breastfeeding
or skin-to-skin care, or case management of neonatal
sepsis since these topics are reviewed elsewhere [36-39].
Delivering in a facility with a skilled attendant and
access to emergency obstetric care has the potential to
reduce stillbirths [40], maternal deaths and also neonatal
deaths from causes other than infection [41], and these
outcomes are also considered in other reviews.
Objective
The objective of this review is to estimate, for use in the
Lives Saved Tool (LiST), the effect of clean practices at
birth and during the postnatal period on all-cause neo-
natal mortality, cause-specific mortality from sepsis and
tetanus, and infection-related morbidity (e.g. sepsis and
omphalitis).
Methods
This review uses an adaptation of the GRADE approach
and is designed to provide estimates for use in LiST
which models cause-specific deaths averted by increases
in coverage of effective interventions. Details of the gen-
eral review methods, the adapted GRADE approach and
the LiST model have been described elsewhere [42].
Searches
We systematically reviewed the published literature to
identify studies of clean birth and postnatal practices for
the prevention of neonatal sepsis and tetanus mortality
and morbidity from 1980 until February 2010. We
searched PubMed, EMBASE, Cochrane Libraries, and all
WHO Regional Databases and included publications in
any language [42]. Combinations of the following search
terms were used: “clean/safe birth/delivery +/- kit”,
“tetanus,”, “sepsis,”“ meningitis,”, “infection,”“ omphalitis/
oomphalitis”, “hygiene,”“ hand washing,”“ umbilical cord
care,”“ skin care,”“ neonatal/perinatal mortality”, “new-
born care”, ”chlorhexidine”, “home birth”, “Latin Amer-
ica/Africa/Asia or developing country” limited to
newborn 0 – 28 days.(Figure 2, and web annex for
details of strategy) After initial screening of titles and
abstracts we reviewed full text publications of potentially
eligible studies. Snowball searching was used whereby
literature referenced in key papers was also searched,
including grey literature.
Studies were considered that reported on neonatal/
perinatal mortality, neonatal tetanus, sepsis, and menin-
gitis or cord infection.
Inclusion/exclusion criteria
We applied the PICO format (Population, Intervention,
Comparison, and Outcome) as follows. The population
of interest was neonates. The interventions being
reviewed are defined below and in table 1 and were
compared to the absence of clean birth and postnatal
practices. The outcomes of interest were overall neona-
tal mortality, neonatal mortality from sepsis or tetanus,
and neonatal morbidity (sepsis or cord infection) as
defined below. We considered both randomised trials
and observational studies (Figure 2). We excluded stu-
dies not fulfilling the inclusion criteria and any dupli-
cate reports of trials or studies, studies that included
clean practices as part of a package of multiple co-
interventions, studies based in specialised populations
and case-control, cohort and cross-sectional studies
which made no attempt to adjust for confounding.
Possible adverse effects of the interventions were not
addressed as part of this review.
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Interventions considered in this review include clean
birth practices at home or in a health facility, including
hand washing, clean cord cutting and tying, clean birth
surface, clean perineum, topical antiseptic applications
to the cord and skin, and clean birth kit use. In addition
clean postnatal newborn care practices and applications
to the birth canal, umbilical cord or skin were reviewed
(Table 1). The effect of a single-use package of com-
modities designed to facilitate a clean birth at home or
in a health facility (a clean birth kit (CBK)) was consid-
ered. A CBK was defined as a disposable package
SEARCHTERMS
‘’handwashing”“hygiene”“umbilicalcordcare”“skin
care”“clean/safedelivery+/Ͳ kit”“tetanus”“sepsis”
“meningitis”“infection”“omphalitis”“neonatal/perinatal
mortality”“chlorhexidine”“homebirth”“newborncare”
“latin America/Africa/Asia/developingcountries”
DATABASES
Pubmed,Cochrane,AFRO,
LILACSandEMRO
Totalsearchresults=781:
Pubmed =768,
Cochrane=4,
Other=9
Studiesremainingafter
screeningtitleorabstract
(n=61)
38Studies
Cleanbirthpractices
n=15
Neonatalmortalityn=1
Neonataltetanusn=10
Cordinfectionn=4
Applicationstocord/skin/
vagina
n=17
Neonatalmortalityn=6
Neonatalteanusn=7
Sespis/nosocomial
infections
n=4
Handwashinginpostnatal
period
n=2
Cleanbirthkits
n=9
Neonatalmortalityn=3
Neonataltetanusn=2
Sepsis/cordinfectionn=6
Excludedn=23
Nocomparisongroup=10
Noadjustingfor
confounding=8
Notastudy=3
Duplicatepublication/
other=2
Figure 2 Search strategy and results.
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Page 4 of 19containing at least the minimum commodities required
to facilitate clean cutting and tying of the umbilical cord
e.g. a clean blade, clean cord tie or clamp.
From a programmatic viewpoint, how to change com-
plex behaviours and cultural norms that govern prac-
tices around the time of birth is of great importance,
but is not the focus of this paper (Figure 1).
Neonatal outcomes definitions
We used cause of death definitions consistent with the
Child Health Epidemiology Reference Group (CHERG)
based on ICD 10 rules [1,43]. Our outcomes of interest
were neonatal tetanus or neonatal sepsis (sepsis/septi-
caemia, meningitis). When no cause-specific data were
available, all-cause neonatal mortality was considered.
When no effect on neonatal mortality was available, the
following neonatal morbidity outcomes were considered:
a) neonatal sepsis; b) omphalitis / cord infection. For
both of these morbidities, standardisation of diagnosis
both within and between studies is problematic. Studies
using different clinical definitions were included in the
review, and differences between case definitions are
described where relevant (Table 2).
Abstraction, analyses and summary measures
All studies meeting the inclusion criteria were
abstracted onto a standardised abstraction form for each
outcome of interest [42]. Each study was assessed and
graded according to the CHERG adaptation of the
GRADE technique [44]. The evidence was summarised
by outcome including a qualitative assessment of study
quality and sources of bias adapted from the Cochrane
review handbook [42]. CHERG Rules for Evidence
Review were applied to the collective evidence to
provide an estimate for reduction in neonatal mortality
from sepsis and neonatal tetanus [42]. Meta-analyses
were conducted when appropriate with STATA version
10.0 statistical software [45]. Heterogeneity was assessed
using I
2 and the chi-squared test. When evidence of het-
erogeneity was present (p<0.10), a random effects model
was used, otherwise a fixed effect was assumed. Sum-
mary risk ratios and corresponding 95% confidence
intervals (CI) are reported.
Delphi expert consensus panel
For interventions with low or very low quality evidence,
we sought expert consensus via the Delphi method [46].
T h eq u e s t i o n n a i r ew a sd e v e l o p e db yJ L ,H B ,A C La n d
Wendy Graham and piloted prior to use. The Delphi
form included the background and aims of the Delphi
process and requested eight different neonatal effect
estimates and 2 maternal effects estimates (Additional
File 1). Respondents were allowed the option of anon-
ymous response. The median response, range, and inter-
quartile range were determined for each question. Con-
sensus was defined a priori as having been achieved
when the inter-quartile range of responses to a given
question was ≤ 30%. The process was repeated until
consensus was reached.
Results
Our searches identified 778 records, and snowball
searching identified a further three papers. (Figure 2)
After initial screening of the title or abstract, we
reviewed 61 papers for data on the outcome measures
of interest. Twenty three papers did not fulfil the inclu-
sion criteria and were excluded (Figure 2). Thirty eight
papers were included in the final database (Additional
File 2). Four relevant Cochrane Reviews were identified.
One review of topical umbilical cord care at birth found
no evidence of benefit of topical antibiotic or antiseptic
applications in high income countries, but no data from
low income settings were included in the review [47].
The second, a study of topical ointment for preventing
infection in preterm infants, reviewed four facility-based
studies from high income countries and concluded that
prophylactic topical ointments should not be used for
premature babies in high-income settings due to an
increased risk of nosocomial and other infections in the
treated group [48]. The final two reviews examined the
effect of vaginal cleansing with chlorhexidine on Group
B streptococcus [49] and other neonatal infections in
high-income countries [50]. Whilst cleansing reduced
colonisation with Group B streptococcus, no other ben-
efits in terms of sepsis morbidity or mortality were
observed.
The remainder of this review focuses on studies car-
ried out in low/middle income countries where the
Table 1 Definitions of interventions considered regarding
clean practices at birth and in the postnatal period
1) Clean birth practices:
a. Place of birth (facility or home)
b. Hand washing (birth attendant before birth, with soap)
c. Clean perineum (washed prior to birth)
d. Clean birth surface (new/ clean plastic sheet or mat)
e. Cutting of the umbilical cord using a clean implement (new or boiled
blade, or clean scissors)
f. Clean cord tying (using a new, clean thread to tie cord or cord
clamp)
2) Hygienic cord and skin care (mainly postnatal):
a. Combined chlorhexidine cleansing of the birth canal prior to birth
and/or full body newborn cleansing immediately after birth
b. Chlorhexidine to the cord
c. Other antimicrobial applications to the cord
d. Avoidance of harmful cord applications
e. Skin applications and emollients
3) Other clean postnatal newborn care practices:
a. Hand washing (maternal during the postnatal period, with soap)
b. Exclusive breast feeding (considered in a separate review)
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Page 5 of 19effect of the clean practices is likely to be larger, and the
evidence more applicable to decision makers in the
countries using the LiST tool. The order of the results
section follows the list in table 1
1. Evidence for the effect of clean birth practices
a. Place of birth
Most studies of clean birth practices are carried out in
populations with high rates of home birth. Direct evi-
dence for the effect of clean birth practices in a facility
compared to clean birth practices at home on overall
neonatal mortality or sepsis-related mortality is complex
to assess given multiple confounders. Four studies
reported a reduced risk of neonatal tetanus associated
with facility delivery after adjusting for potential con-
founders [adjusted odds ratio (aOR) 0.56 (95% confi-
dence interval (CI) 0.32 – 0.91)[51], aOR 0.22 (95% CI
0.04 – 1.25) [52], aOR 0.08 (95% CI 0.003 – 0.63) [53],
aOR 0.66 (95% CI 0.07 – 5.88) [54]]. (Figure 3)
Another study reported a crude neonatal mortality OR
of 0.22 (95% CI 0.08 – 0.71) [55], but reported no asso-
ciation after adjusting for potential confounders. Multi-
v a r i a t ea n a l y s i so fas t u d yf r o mT a n z a n i ai n d i c a t e da
reduction in cord infection if a broad definition (pus
with any degree of redness) was used [adjusted rate
ratio (aRR) 0.38 (95% CI0.19 – 0.78)] amongst hospital
births when compared to home births [56]. However,
when a more restrictive definition was used (moderate
or severe redness), an increase in cord infection was
seen in hospital births [aRR 2.05 (95% CI 1.12 – 3.72)].
Three further studies found no difference in cord infec-
tion rates between home and facility deliveries [57-59].
b. Hand washing of birth attendant with soap before birth
Eight observational studies that adjusted for confound-
ing were identified. Four community-based case-control
studies and one cohort study reported the effect of birth
attendant hand-washing on tetanus-specific neonatal
mortality in rural populations. The aORs were all below
1, consistent with a protective effect of hand-washing
(Figure 4a) [60-63]. Combining the four studies which
provided point estimates and CIs resulted in a pooled
effect estimate of 0.51 (95% CI. 0.38 – 0.65). (Figure 4a)
The final study provided a point estimate of aOR=0.19
(p<0.001) [64]
One large cohort study (n=23,662 with 713 deaths)
reported lower neonatal mortality associated with
reported birth attendant hand-washing with soap and
water (aRR=0.81: 95% CI 0.66 – 0.99) [21]. No cases of
neonatal tetanus were documented in this study popula-
tion with near universal coverage of antenatal tetanus
toxoid coverage and access to CBKs. This study and
a further cohort study from Nepal also reported
Table 2 Cord infections and sepsis definitions used in the included studies
Neonatal Outcome and
Study
Definition Used
Neonatal Sepsis Mortality
Bakr 2005 Positive microbiological cultures or clinical and laboratory criteria very suggestive of sepsis (e.g., temperature instability,
poor feeding, apnea, irregular respiration, positive C-reactive protein [CRP] and micro-erthrocyte sedimentation rate
[micro-ESR]) and died in first 28 days of life.
Taha 1997 Paediatricians diagnosed on the basis of clinical criteria of temperature > 38.0°C, poor feeding, and apnoea or irregular
respiration and died in first 28 days of life.
Cutland 2009 Culture-confirmed or clinical sepsis on the basis of clinical and laboratory signs and died in first 28 days of life.
Mullany 2006 Presence of 2 or more of the following signs or symptoms: (1) caregiver’s report of fever; (2) vomiting more than half of
feeds; (3) unconsciousness; (4)bulging fontanelle; (5) feeding difficulty (not able to suck before death or feeding less
thannormal); (6) skin or umbilical cord infection (pus discharge from the cord stump); (7) jaundice;and (8) difficulty
breathing and either rapid breathing or chest indrawing and died in first 28 days of life.
Neonatal Sepsis Incidence
Cutland 2009 Culture-confirmed or clinical sepsis on the basis of clinical and laboratory signs
Saleem 2007 Neonates who were severely ill according to Integrated Management of Childhood Illness AND had a clinical
presentation, maternal history, and involvement of at least one organ system and laboratory findings; or a maternal
history supporting infection; or had no evidence of a nonseptic condition to account for their condition
Garner 1994 Based on clinical assessment of study physician
Cord Infection / Omphalitis
Tsu 2000 Used colour photos of normal and infected cord stumps and questions re redness and pus; interviewer assessment and
final decision by neonatologist review of this info (rating it as “definite”,“probable”, “possible”,o r“unlikely”)
Mullany 2006/7 “Mild” redness (or swelling) was limited to the cord stump, while “moderate” or “severe” was defined as inflammation
extending to the skin at the base of the stump (i.e., <2 cm extension onto the abdominal skin) or affecting an area 2 cm
or more from the cord, respectively
Winani 2007 Inspection of umbilical stump by village health worker for signs of possible infection, including erythema, tenderness of
tissues surrounding the cord, pus discharge, or smelly or moist stump. Diagnosis confirmed by physician.
Darmstadt 2009 Redness, oozing, or bleeding of umbilical stump
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with birth attendant hand-washing: aRR=0.73 (95% CI
0.64 – 0.84) [11] and aRR=0.58 (95% CI 0.40 – 0.84)
[58], respectively. (Figure 4b)
c. Clean perineum (washed prior to birth)
Two case-control studies reported no association after
adjustment between cleaning the perineum, with soap
and water, and reduction in the incidence of neonatal
tetanus [51,65]. No evidence on the effect of cleaning of
the perineum on sepsis or infection was identified.
d. Clean birth surface (new or clean sheet or mat)
Two case-control studies controlling for potential con-
founders examined the association between using a
clean plastic sheet as a birth surface and incidence of
neonatal tetanus and reported aOR=0.31 (95% CI 0.10 –
0.91)[66] and aOR=0.03 (95% CI 0.002 – 0.34) [55]. One
cohort study from Tanzania, with nearly universal kit
use in the study population, did not find evidence of a
protective effect of using a clean plastic sheet on inci-
dence of cord infection after adjusting for potential con-
founding factors. However, the adjusted relative risk is
not presented [56].
e. Cutting of the umbilical cord using a clean implement
Seven observational studies (4 case-control, 2 cohort, 1
adopter vs. non-adopter) were identified which exam-
ined the association of using a clean implement (a new/
boiled/ sterile blade or scissors) to cut the cord with
neonatal sepsis or tetanus.
Five of these studies from Asia and one from Senegal
examined the effect on neonatal tetanus incidence or
mortality. Two case-control studies and one cohort
study which sought to adjust for confounders reported
strong evidence of lower neonatal tetanus mortality
associated with use of clean cord cutting tools [aOR=0.3
(95% CI 0.13 – 0.62)[60], aOR=0.4 (95% CI 0.24 – 0.66)
[61], and aOR0.25 (95% CI 0.08 – 0.75)][63].Three stu-
dies did not find strong statistical evidence of an asso-
ciation between tetanus and the use of an old razor
blade or scissors versus a new blade after controlling for
potential confounders but no parameter estimates were
reported [51,64,66].
One study of clean birth kits from Tanzania examined
the effect of the use of a new blade on cord infection.
There was no reduction in cord infection associated
with the use of new blades [aOR=1.1 (0.43 – 3.05)].
However, the level of new blade use was >95%, and
those not using new blades may have used boiled blades
[59].
f. Clean cord tying
Four case-control studies examined the association
between use of a ‘new clean thread’ to tie the umbilical
cord at birth and neonatal tetanus incidence or mortal-
ity. A study from Uganda using hospital-based cases
reported an aOR of 0.1 (95% CI 0.01 – 1.1) for clean
cord tie use [55]. The three other studies reported no
difference after adjusting for potential confounders, but
do not present adjusted odds ratios [52,64,66].
An urban community case-control study compared
use of a cord clamp versus ‘thread’ to tie the cord, and
found no evidence of a difference in tetanus incidence
between the two groups in multivariate analysis, where
home birth and cord applications were the most impor-
tant risk factors [51]. A cohort study in Tanzania did
not observe any association between use of the clean
birth kit thread and incidence of cord infection [56], but
use was near-universal.
Overall  (I-squared = 39.4%, p = 0.175)
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Gupta 1998
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Chai 2004
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ID
0.32 (0.12, 0.53)
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Figure 3 Meta-analysis of neonatal tetanus variation with facility birth compared to non-facility birth controlling for major confounders (maternal
education, tetanus toxoid immunization, care knowledge/ practices).
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a. Combined chlorhexidine cleansing of the birth canal
prior to birth and/or full body newborn cleansing
immediately after birth
Vaginal washing with chlorhexidine has been shown to
reduce colonization rates with Group B streptococcus in
high income countries [49]. The most recent Cochrane
review found no strong evidence of an effect on neona-
tal infections [50]. Five low and middle income country-
based studies were examined which all used both vaginal
and neonatal wipes. Two before-and-after hospital-based
studies in Egypt and Malawi reported reductions in
infection-related neonatal mortality with chlorhexidine
compared to routine care [RR=0.26 (95% CI0.1 – 0.7)
[67] and RR=0.33 (95% CI 0.15 – 0.70)[68].
A community-based pilot randomized controlled trial
(RCT) from Pakistan of chlorhexidine versus saline vagi-
nal and neonatal wipes did not report infection-specific
outcomes and was too small to conclude anything with
respect to neonatal mortality [RR=0.20 (95% CI 0.01 –
4.03)] [69]. A large randomised controlled trial (RCT)
from South Africa based in a hospital with low infection
rates did not find evidence of a difference in rates of
sepsis with chlorhexidine vaginal and neonatal wipes
compared to external genitalia water wipes and neonatal
chlorhexidine foot wipes RR=0.95 (95% CI 0.76 – 1.19)
[70]. Consistent with this finding, a recent large RCT
based in three hospitals in Pakistan, which compared
chlorhexidine vaginal and neonatal wipes to saline pla-
cebo wipes, found no difference in the primary study
4 a) Neonatal tetanus: 
Overall  (I-squared = 14.0%, p = 0.322)
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0.42 (0.15, 1.25)
0.49 (0.30, 0.81)
100.00
44.70
Weight
20.20
6.21
28.89
%
1 .1 1
4b) Cord infection: 
Overall  (I-squared = 32.4%, p = 0.224)
ID
Mullany 2007
Study
Tsu 2000
0.70 (0.61, 0.80)
ES (95% CI)
0.73 (0.64, 0.84)
0.58 (0.40, 0.84)
100.00
Weight
82.88
%
17.12
0.70 (0.61, 0.80)
ES (95% CI)
0.73 (0.64, 0.84)
0.58 (0.40, 0.84)
100.00
Weight
82.88
%
17.12
1 .1 1
Figure 4 Meta-analysis of the effect of birth attendant hand washing before birth: 4a) On neonatal tetanus 4b) On cord infection.
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Page 8 of 19outcome (7 day neonatal mortality or neonatal sepsis)
between the groups RR=0.91 (95%CI 0.67 – 1.24) or
overall neonatal mortality at 28 days RR=0.98 (95% CI
0.68 – 1.41) [71].
A large community-based cluster RCT of skin cleans-
ing with chlorhexidine (0.25%) as soon as possible after
birth without vaginal cleansing did not find evidence of
a reduction in neonatal mortality among all treated
infants (RR=1.04; 95% CI:0.87 – 1.24). In a sub-analysis
among low birth weight infants, those wiped with chlor-
hexidine experienced lower neonatal mortality than the
placebo group (RR: 0.72; 95% CI: 0.55–0.95) [72].
b. Chlorhexidine applied to the cord postnatally
In a RCT, chlorhexidine cleansing of the cord in rural
Nepal reduced all-cause neonatal mortality (RR = 0.66
[0.46 – 0.95]) and sepsis-specific neonatal mortality
(RR=0.69 (95% CI 0.4 – 1.18) if applied within the first
24 hours [73]. Chlorhexidine cleansing also reduced
mild (RR=0.68 (95% CI 0.58 – 0.80), moderate (RR=0.46
(95% CI 0.36 – 0.59) and severe cord infection (RR=0.25
(95% CI 0.12 – 0.53), signs that are related to subse-
quent risk of mortality [12]. A follow-up efficacy trial in
northeast Bangladesh and an effectiveness trial in rural
Pakistan have been completed and will be reported
shortly. The effectiveness of this intervention is cur-
rently being evaluated in two randomized trials in sub-
Saharan Africa.
c. Other postnatal cord antimicrobial applications
Four case-control studies reported that cord applications
of topical antimicrobials were associated with reduced
neonatal tetanus incidence compared with dry cord
care. The reported associations found for topical anti-
biotics were [aOR=0.21(95% CI 0.05-0.97))][62] and
[aOR=0.37 (95% CI 0.25 – 0.74)][74]); for disinfectants
[aOR=0.69 (95% CI 0.41 – 1.19)] [62]; and for any anti-
microbial [aOR=0.4 (95% CI 0.21 – 0.77)][75] and
[aOR=0.48 (95% 0.15 – 1.4)] [51], based on author’s
definitions. Combining these studies results in a pooled
estimate aOR for the effect on neonatal tetanus of any
antimicrobial to the cord of 0.37 (95% CI 0.14 – 0.59)
(Figure 5). Regular antimicrobial applications during the
postnatal period were associated with reduction in teta-
nus [aOR=0.38 (p=0.026)] [75].
d. Avoidance of harmful postnatal cord applications
Evidence from case-control studies supports an associa-
tion between neonatal tetanus and applications of cow
dung or ash to the cord [aOR=2.31 (95% CI 1.03 –
5.03)][62], traditional applications (mustard oil, ghee or
surma) to the cord [aOR=5.1 (95% CI 2.7 – 9.7)] [51],
shea butter [aOR 6.4 (95% CI 1.6 – 21.4)] [76] and ghee
(in particular cow’s milk ghee) [aOR=1.94 (95% CI 1.07
– 3.53)] [74].
Consistent with the effect on neonatal tetanus, in one
cohort study in Nepal, mustard oil application was asso-
ciated with an increased risk of cord infection
[aRR=1.29 (95% CI 1.11 – 1.51)] [11]. However, in a
study in The Gambia application of shea butter was
associated with reduced all-cause neonatal mortality
[aRR=0.32 (95% CI 0.13 – 0.76)] [5].
e. Other postnatal skin applications including emollients
Two RCTs of hospitalized preterm infants of less than
33 weeks gestational age demonstrated reductions in
nosocomial bloodstream infections with topical applica-
tion of emollients(sunflower oil) [aRR=0.46 (95% CI
0.26–0.81) and aRR=0·59 (95%CI 0·37–0·96)) [77,78].
These studies also reported reductions in all cause
Overall  (I-squared = 0.0%, p = 0.731)
Parashar 1998
Study
Raza 2004
Bennett 1997
ID
0.37 (0.14, 0.59)
0.21 (0.05, 0.97)
0.48 (0.15, 1.40)
0.40 (0.21, 0.77)
ES (95% CI)
100.00
23.58
%
12.77
63.65
Weight
0.37 (0.14, 0.59)
0.21 (0.05, 0.97)
0.48 (0.15, 1.40)
0.40 (0.21, 0.77)
ES (95% CI)
100.00
23.58
%
12.77
63.65
Weight
1 .1 1
Figure 5 Meta-analysis of the effect of antimicrobial applications (antibiotics or disinfectants) to cord on neonatal tetanus.
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Page 9 of 19neonatal mortality (sunflower oil [aRR 0.74(95% CI:
0.55–0.99) and using Aquaphor [aRR 0.67 (95% CI:
0.51–0.92)] [79]) in these preterm infants.
However, evidence of benefit is currently limited to
inpatient preterm infants. There are currently no data
on the benefit of emollients in term infants; nor is it
known if the hospital-based findings among very pre-
term infants apply to those born at home. Two large
community RCTs are currently being undertaken in
India and Nepal, the results of which may provide
further evidence on which to base a community-level
recommendation.
3. Evidence for the effect of postnatal maternal
handwashing
One cohort study from Nepal found that reported that
regular maternal hand-washing in the first 14 days of
life was associated with reductions in both omphalitis
[aRR=0.76 (95% CI 0.60 – 0.95)] [11] and all-cause neo-
natal mortality [aRR= 0.56 (95% CI 0.38 – 0.82)] [21].
Evaluations including clean birth kit use
Three studies using clean birth kits have reported effects
on overall neonatal mortality. One before-and-after
study reported a 22% reduction in all-cause neonatal
mortality, OR 0.78 (95% CI 0.50 – 1.21), after introduc-
tion of clean birth kit use into an existing lady health
worker-delivered package of antenatal/ birth care [80].
An 80% reduction in neonatal tetanus deaths [OR=0.20
(95% CI 0.01 – 4.18)] was also observed, explaining
much of the reduction in neonatal mortality. However,
increased tetanus toxoid immunisation coverage, from
70 to 93% during the study period, will have contributed
to this reduction, and the relative contribution of the
clean birth kits cannot be assessed. A quasi experimen-
tal study of a clean birth kit and education package
introduced to a Masai population with constant levels of
tetanus immunisation coverage indicated that mortality
in the first six weeks of life was reduced in the interven-
tion areas [unadjusted RR=0.17 (95% CI 0.13 – 0.23)]. A
dramatic reduction in neonatal tetanus deaths [unad-
justed RR=0.01 (95% CI 0.001 – 0.09)] was also seen
[18]. In this setting, however, local practice included
packing the umbilical stump with cow dung, and the
baseline neonatal tetanus incidence was very high, rais-
ing concerns about the generalisability of the findings.
One cluster RCT of a TBA-delivered package of antena-
tal, intrapartum and postnatal care with education and
improved referral included clean birth kits and reported
a 29% reduction in neonatal mortality (aOR=0.71; 95%
CI 0.62 – 0.83) [81]. All three studies had multiple co-
interventions and were hence excluded.
One further study, also reporting on neonatal sepsis
and cord infection, was excluded as ‘newborn care kits’
were given, which included soap and spirits, but no blade
or cord tie [4,82]. Three additional case-control studies
were excluded, as they did not report adjusted OR for the
effect of clean birth kits on neonatal tetanus [51,62,83].
One before-and-after study reported an 89% reduction
in neonatal sepsis after the introduction of clean birth
kits for home births [unadjusted OR=0.11 (95% CI 0.01
– 0.84) [84].
Four cross-sectional studies examined the association
between clean birth kits and incidence of cord infec-
tion. They used different definitions for cord infection
and showed marked heterogeneity. All studies com-
pared clean birth kits users (adopters) with non-users
(non-adopters). In three studies the kits were distribu-
t e df r e eo fc h a r g eb yh e a l t hw o r k e r s[ 1 1 , 5 7 , 5 9 ] .I nt h e
fourth study, clean birth kits were marketed using
mass media and made available for purchase at a sub-
sidized price [58]. One study from Tanzania which
reported a very low incidence of cord infection (1.7%),
possibly due to a narrow case definition and the fact
that suspected cases were required to attend the near-
est health facility for confirmation of the diagnosis,
observed a reduced incidence of cord infection in
clean birth kit users [OR=0.08 (95% CI 0.03 – 0.19)]
[59]. A study from Nepal reported 16% incidence of
cord infection and found no evidence of a difference in
cord infection between kit users and women who used
a new or boiled blade to cut the cord [RR=1.09 (95%
CI 0.75 – 1.43)], but benefit of kit use when compared
to women who used a boiled or other blade to cut the
cord on a dirty surface [aRR=0.45 (95% CI 0.25 –
0.81)] [58]. A study from Egypt reported a 8.2% inci-
dence of cord infection, with a lower risk amongst kit
users [aOR=0.42 (95% CI 0.18 – 0.97)] [57]. A study
from Nepal reported that only the use of the soap was
associated with a reduction in omphalitis (aRR=0.49
(95% CI 0.43 – 0.56)) [11], with no effect seen with
any of the other kit components. Near-universal use of
the other kit components prevented this study from
assessing the associations of these components with
risk of infection.
A study from Pemba, Tanzania found an increased
risk of infection with use of a plastic cord cutting coin
surface [56]. This study achieved near universal use of
the other kit components and hence was not able to
assess the associations of these components with the
risk of infection.
Overall level of evidence
Place of birth
Four studies report a protective association of neonatal
tetanus with facility birth. No strong evidence of a rela-
tionship between place of birth and cord infections was
found.
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Page 10 of 19Hand-washing with soap prior to birth
Published data from four low or very low quality studies
[60-63] are consistent in suggesting a reduction in teta-
nus mortality of 49% (95% CI 35 – 62%). A single study
suggested benefit on all-cause neonatal mortality of 19%
(95% CI 1 – 34%) [21]. Two low quality studies are con-
sistent in suggesting a reduction in cord infection of
30% (95% CI. 20 – 39%) [11,58] (Table 3).
Other clean birth practices
All studies are consistent with a beneficial effect of clean
birth practices; however the data currently available are
inadequate to evaluate the size of the effect of a clean
cord cutting implement, clean perineum, clean cord tie
or clean birth surface on mortality from neonatal sepsis.
Limited data on the effects on cord infection were
found, however, these were single studies providing low
quality evidence and the outcome was distal to the out-
come of interest (mortality from neonatal sepsis).
Low quality evidence of no association of a clean peri-
neum with the incidence of neonatal tetanus, and a
reduced incidence with a clean birth surface was found.
Much heterogeneity was found in the six very low qual-
ity studies reporting the effect of a clean cutting imple-
ment and four very low quality studies reporting the
effect of a clean cord tie on neonatal tetanus incidence.
The overall of the evidence was low. (Table 3)
Cord and skin applications
Evidence from three very low quality studies suggests a
63% (95% CI 41 – 86%) reduction in neonatal tetanus
mortality with antimicrobial applications to the cord. A
community-based cluster RCT and two facility-based
R C Th a v en o tf o u n de v i d e n c eo fab e n e f i ti nm o r t a l i t y
reduction of chlorhexidine skin applications with or
without chlorhexidine vaginal cleansing [70-72]. A single
cluster RCT of chlorhexidine applications to the cord
found a reduction in neonatal mortality of 33% (95% CI
5 -54%)[73], but there is currently insufficient evidence
to support inclusion of this intervention in LiST. (Table
4) The results of two further trials from Asia will soon
be available and further analysis including these results
is planned [85]. Any recommendation to change the
current WHO recommendation for dry, clean cord care
in low-resource settings awaits further evidence.
Two high quality studies found evidence that topical
emollients reduce nosocomial infections and one study
reported a reduction in neonatal mortality in hospita-
lized preterm infants [77-79].
Clean postnatal newborn care practices
One study provided supportive evidence of an effect of
maternal hand-washing in the postnatal period on all-
cause neonatal mortality of 44% (95% CI 18 – 62%) [21].
Clean birth kit use
One very low quality study reported a reduction in neo-
natal sepsis of 89% (95% CI 16 – 99%) [84]. Four studies
of the effect of clean birth kits on cord infection showed
heterogeneous results. (Table 5)
Due to concurrent interventions (including education,
tetanus toxoid immunization, newborn care packages)
and contextual factors, the generalisability of the
remaining study findings reviewed is unclear. Hence,
whilst the available data supports that clean birth kit use
as part of a ‘package’ has an effect on neonatal mortality
from sepsis and tetanus we were unable to estimate the
individual contribution of clean birth kit use on this
mortality reduction.
GRADE recommendation and results of Delphi process
Low quality evidence was found for the effect of hand
washing and for antimicrobial applications to the cord
on mortality from neonatal sepsis and tetanus. Very low
quality or no evidence was found for the other clean
practices reviewed. This is counter balanced with the
ethical complexity of randomised trials of what is a stan-
dard of care throughout the world. The GRADE recom-
mendation for clean practices is strong. Given this
recommendation, and as the objective of this review is
to establish mortality effect estimates for clean practices
with transparent methodology, a Delphi expert consen-
sus was undertaken. The panel invited to participate
included experts in obstetrics, gynaecology and newborn
health representing five WHO regions (South Asia,
Africa, Western Europe, North America, Latin America
Caribbean), and including multiple disciplines - pro-
gramme management, research, obstetrics, and paedia-
trics. Thirty experts participated.
Consensus was reached in the first round for all inter-
ventions to reduce neonatal mortality. Experts judged
that clean birth practices at home with no skilled atten-
dant could avert 15% (IQR 10 – 20) of sepsis-related
and 30% (IQR 20 – 30) of tetanus-related neonatal
deaths. Skilled attendance at home was judged to avert
23% (IQR 19 – 30) of sepsis-related and 35% (IQR 30 –
40) of tetanus-related neonatal deaths. Skilled atten-
dance in a facility was judged to increase this to 27%
(IQR 24 – 36) of sepsis-related and 38% (IQR 34 – 40)
of tetanus-related deaths. Clean newborn care practices
in the postnatal period were judged to avert 40% IQR
25 – 50) of sepsis-related and 40% (IQR 30 – 50) of
tetanus-related deaths. (Table 6)
Discussion
The primary finding and main limitation of this review
is the lack of high or moderate quality evidence for the
effect of clean birth and postnatal newborn care prac-
tices on neonatal mortality, particularly those relevant
for low and middle income countries where the impact
would be the greatest. In addition there is likely to be
publication bias for positive studies. Even within
Blencowe et al. BMC Public Health 2011, 11(Suppl 3):S11
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Quality Assessment Summary of Findings
Generalisability Intervention Control
No of
studies
(ref)
Intervention Design Limitations of studies Consistency To
population
of interest
To
intervention
of interest
GRADE of
evidence
No.
events
No.
births
No.
events
No.
births
Effect size
(95% CI)
Neonatal Mortality (Tetanus Deaths):
4 (60 - 64), Birth Attendant hand
washing prior to delivery
1 Cohort, 4
Case Control
Very low quality Consistent All rural
populations
Yes Low aOR = 0.51
(0.38 - 0.65)*
2 (55,66) Clean delivery surface 2 Case
control
Very low quality Consistent Uganda and
Pakistan
Yes Low aOR = 0.07
(0.00 - 0.23)*
2 (51, 62) Clean perineum 2 Case
Control
Very low quality Consistent Both from
Asia
Yes Low No association
reported^
6 (51, 54,
60 - 61,
66)
Clean cord cutting tool 1 Cohort,
4 Case
Control
Low quality, Co-
interventions (adjusted
for TT)
Heterogeneous 5 from Asia Yes Low aOR 0.25 - 0.4^^
4 (52, 55,
64, 66)
Clean cord tie 4 Case
Control
Very low quality Heterogeneous Yes Yes Low single study aOR
= 0.1
(0.01 - 1.1)
3 studies no
association
reported^
3 (51, 62,
75)
Antimicrobial cord
applications
3 Case
Control
Very low quality Consistent All from Asia Yes Low aOR = 0.37*
(0.14 - 0.59)
Neonatal Mortality (Sepsis Deaths):
No studies identified
Neonatal Mortality (All Cause):
1 (21) Birth Attendant hand
washing with soap prior to
delivery
Cohort Co-interventions
(adjusted for
chlorhexidine)
Single study
Nepal
Yes Low 371 13,255 342 9123 aRR = 0.81
(0.66 - 0.99)
1 (21) Postnatal maternal
handwashing
Cohort Co-interventions
(adjusted for
chlorhexidine)
Single study
Nepal
Yes Low 30 3403 427 19,592 aRR = 0.56
(0.38-0.82)
Neonatal Sepsis incidence:
No studies identified
Cord infection/oomphalitis
2 (11,58) Birth Attendant hand
washing prior to delivery
1 Cohort,
1 Observ-
ational
Consistent Nepal only Yes Moderate 470** 9645** 421** 5990** aRR = 0.73*
(0.64 - 0.84)
1 (59) Clean cord cutting tool Cohort Low quality Single study
from
Tanzania
Yes Low 48 2891 5 111 aOR = 1.1
(0.43 - 3.05)
1 (11) Postnatal maternal
handwashing
Cohort Low quality Single study
Nepal
Yes Low 95 2206 539 8960 aRR = 0.76
(0.60 - 0.95)
**only available for study (11).
*from pooled analysis ^studies did not report aOR^^199 NT cases, 3 studies. 3 studies report no association but did not present aOR.
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9Table 4
Quality Assessment Summary of Findings
Generalisability Intervention Control
No of
studies (ref)
Intervention Design Limitations Consistency To population of
interest
To intervention of
interest
GRADE of
evidence
No.
events
No.
births
No.
events
No.
births
Effect
size
(95% CI)
Neonatal Mortality (Tetanus Deaths):
No studies identified
Neonatal Mortality (Sepsis Deaths):
3 (67, 68, 70) Chlorhexidine vaginal and
baby wipes
1R C T ,
2 Before
and after
Hospital based
studies
Heterogeneity S.Africa, Malawi,
Egypt
Yes Moderate 21 10108 55 9612
1 (73) Chlorhexidine to cord
(day 1)
cRCT ˇ Single study Nepal Yes Moderate 3134 3179 RR = 0.69
(0.40 -
1.18)
Neonatal Mortality (All Cause):
1 (73) Chlorhexidine to cord cRCT Single study Nepal Yes Moderate 72 4924 98 5082 RR = 0.78
(0.57 -
1.07)*
1 (73) Chlorhexidine to cord
(day 1)
cRCT ˇ Single study Nepal Yes Moderate 45 3134 69 3179 RR = 0.66
(0.46 -
0.95)
1 (72) Chlorhexidine wipes to
baby
cRCT Single study Nepal Yes Moderate 264 860 263 8880 RR = 1.04
(0.87 -
1.24)
1 (72) Chlorhexidine wipes to
baby
cRCTˇ Single study Nepal Low birth weight
babies only
Moderate 83 2448 117 2491 RR = 0.72
(0.55 -
0.95)
1 (71) Chlorhexidine vaginal and
baby wipes
1 RCT Single study Pakistan Yes Moderate 55 2505 56 2503 RR = 0.98
(0.68 -
1.41)
Neonatal Sepsis incidence:
2 (70,71) Chlorhexidine vaginal and
baby wipes
2 RCT Hospital based
studies
Consistent S. Africa, Pakistan Yes Moderate 179 6,577 188 6,560 RR =
0.95^
(0.76 -
1.14)
Cord infection/oomphalitis
1 (73) Chlorhexidine to cord cRCT Single study Nepal Yes Moderate 438 4703 638 4859 RR =
0.68**
(0.58 -
0.80)
ˇsub-group analysis *adjusted for ethnic group, literacy, topical mustard oil applications ^based on pooled analysis **oomphalitis defined as redness extending to the skin at the base of the umbilical stump
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9Table 5
Quality Assessment Summary of Findings
Generalisability Intervention Control
No of
studies
(ref)
Intervention Design Limitations Consistency To
population
of interest
To
intervention
of interest
No.
Events
No.
births
No.
events
No.
births
Effect size
(95% CI)
Neonatal Mortality (Tetanus Deaths):
1 (18) CBK and
education
Before and
after
Low quality Masai
population*
Yes 0 1984 415 5716 RR = 0.01
(0.001 -
0.09)
1 (80) CBK, TT plus
multiple
interventions
Before and
after
Multiple
interventions
India. Lady
health worker
delivered
Multiple
interventions
0 1951 2 1958 OR = 0.20
(0.01 - 4.18)
Neonatal Mortality (Sepsis Deaths):
No studies identified
Neonatal Mortality (All Cause):
1 (81) CBK plus
multiple
interventions
cRCT Multiple
interventions
Pakistan TBA
delivered
Multiple
interventions
340 10092 439 19432 aOR 0.71
(0.62 - 0.83)
1 (18) CBK and
education
Before and
after
Low quality Masai
population*
Yes 99 1984 1984 5716 RR = 0.17
(0.13 - 0.23)
1 (80) CBK, TT plus
multiple
interventions
Before and
after
Multiple
interventions
India lady
health worker
delivered
Multiple
interventions
35 1951 45 1958 OR 0.78
(0.50 - 1.21)
Neonatal Sepsis incidence:
1 (84) CBK and
demonstration
Before and
after
Observational Papua New
Guinea**
Yes 1 67 8 64 OR = 0.11
(0.01 - 0.84)
Cord infection/oomphalitis:
3 (56,
58, 59)
CBK use Adopters
vs non-
adopters
Observational Heterogeneous Egypt,
Tanzania,
Nepal
Yes aOR 0.08-
0.45
1 (11) Use of
individual
items in CBK
Adopters
vs non-
adopters
Observational Nepal Yes soap aRR =
0.49 (0.43-
0.56)^
*Specific cultural practices and defined neonatal death as death occuring in first 6 weeks of life **Specific cultural practices.
^ no effect of other components on multivariable analysis TT = tetanus toxoid vaccination.
Table 6 Results from the Delphi expert consensus process
Median
(%)
Range
(%)
Inter-quartile
Range (%)
Effect on sepsis specific
neonatal mortality
1. Effect of clean birth practices at home without a skilled attendant on
sepsis specific neonatal mortality
15 5 – 30 10 – 20
2. Effect of clean birth practices at home with a skilled attendant on sepsis
specific neonatal mortality
23 10 –
50
19 – 30
3. Effect of clean birth practices in a facility on sepsis specific neonatal
mortality
27 5 – 60 23.75 – 36.25
4. Effect of clean newborn care practices at home during the postnatal
period on sepsis specific neonatal mortality
40 10 –
60
25 – 50
Effect on neonatal mortality
due to tetanus
5. Effect of clean birth practices at home without a skilled attendant on
neonatal mortality due to tetanus
30 5 – 45 20 – 30
6. Effect of clean birth practices at home with a skilled attendant on
neonatal mortality due to tetanus
35 5 – 50 30 – 40
7. Effect of clean birth practices in a facility on neonatal mortality due to
tetanus
38 5 – 80 34 – 40
8. Effect of clean newborn care practices at home during the postnatal
period on neonatal mortality due to tetanus
40 5 – 70 30 - 50
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association of certain clean practices with tetanus or
sepsis-related outcomes, the adjusted effect size was not
reported. The overall quality of evidence for impact of
clean birth and postnatal newborn care practices
reviewed on cause-specific mortality is very low. How-
ever as there is strong biological plausibility and this is
an accepted standard of care, and randomized controlled
t r i a l sw o u l db ec o n s i d e r e du n e t h i c a l ,t h eG R A D E
recommendation for these practices is strong.
The size of the effect of clean birth and postnatal care
practices is important to quantify, and to our knowledge
this is the first such estimate. Following the rules estab-
lished by CHERG for interventions with a strong
GRADE recommendation[44], but low level of evidence
, a Delphi expert process was undertaken. We included
a range of experts with wide geographic representation
(geographic region, low-middle and high income set-
tings) and expertise (clinical, epidemiology, obstetrics,
neonatology). They estimated moderate benefits of clean
practices; specifically that clean birth practices may
avert between 15 - 27% of neonatal sepsis deaths and 30
– 38% of neonatal tetanus deaths. Greater benefits were
estimated for clean birth practices by a skilled birth
attendant and in a facility compared to clean birth prac-
tices at home with no skilled attendant. Clean newborn
care practices were estimated to prevent 40% of sepsis
and tetanus neonatal mortality. In total combined clean
facility birth and newborn care practices are estimated
to avert two thirds of neonatal sepsis deaths and over
three quarters of neonatal tetanus deaths when com-
pared to home birth and postnatal care with no clean
practices (Table 7).
Neonatal mortality in high income countries showed a
rapid decline throughout the last century[86]. Much of
this decline occurred before the introduction of immu-
nization, antibiotics and neonatal intensive care into
routine practice. In particular, improved clean practices
around the time of birth, coupled with distancing the
place of birth from potential soil contamination (and
hence tetanus) resulted in a substantial reduction in
neonatal tetanus in these countries prior to vaccine
introduction [14,87]. Historical data and data from
before and after studies suggest higher reductions than
our panel consensus, but such studies may have been
undertaken in settings with higher risk behaviours – eg
the Masai who traditionally placed cow dung on the
umbilical cord. Overall our estimates are likely to be
conservative.
Few would disagree with the principles of clean birth
and postnatal care for all babies, including those born at
home. The benefits of clean care are likely to be positive
with minimal plausible adverse effects of the practices
per se; however several implementation questions
remain important. What is the most appropriate method
to promote behaviour change in this area? What prac-
tices should be focused on? And if practice is changed,
what is the actual cost, the opportunity cost and the
likely effect on lives saved of rolling out the promotion
method as a policy? Strategies to improve uptake of
clean birth and postnatal care practices include commu-
nity-based behaviour change (including women’s
groups), health worker/birth attendant training and spe-
cific vehicles such as clean birth kits. Possible unin-
tended adverse effects of these strategies may exist e.g.
dis-incentivising facility birth. (Table 8) There is increas-
ing evidence from evaluations of packages which include
the promotion of clean birth and postnatal care prac-
tices as package components, showing increased uptake
of clean practices in the intervention groups
[4,30,32,82,88-93]. However as the packages are
intended to affect multiple behaviours at once, it is
Table 7 Cause-specific mortality effect and quality grade
of the estimate for the effect of clean birth and newborn
care practices on neonatal deaths from sepsis and
tetanus for use in LiST
Cause-specific mortality to act on:
Neonatal deaths from sepsis and tetanus
Cause-specific estimate of effect:
Reduction in neonatal deaths from sepsis of 15% with clean birth
practices at home with no skilled attendant, 23% with a skilled
attendant at home and 27% in a facility.
Reduction in neonatal deaths from tetanus of 30% at home with no
skilled attendant, 35% at home with a skilled attendant and by 38% in a
facility.
Clean postnatal newborn care practices are estimated to reduce
neonatal mortality from sepsis by 40% and from tetanus by 40%
Quality of input evidence:
Very low quality– based on Delphi panel consensus
Moderate to very low quality supporting evidence
Table 8 Addressing the knowledge gaps for clean
practices at birth and in the postnatal period
Analysis of existing datasets
Analysis of existing data sets to examine the relationship between clean
birth practices, use of clean birth kits and neonatal mortality/ morbidity,
with improved controlling for confounding variables.
Examination of implementation experiences
Examination of implementation approaches for the promotion of
behaviour change in relation to clean practices, particularly to examine
whether certain strategies for clean birth kits distribution may act as an
incentive or disincentive for facility birth.
New studies
New research studies for example well designed randomised controlled
trials of implementation strategies to improve clean birth and postnatal
practices assessing benefits, feasibility, costs and potential negative
effects of different strategies e.g. education, media, community
mobilisation, clean birth kits.
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ticularly the effects of clean birth and postnatal care
practices in the early postnatal period.
One potential vehicle for promoting clean birth and
postnatal care practices is the clean birth kit. In some
settings, e.g. in conflict or humanitarian emergencies, or
in settings where there is currently low coverage of facil-
ity birth, a working group of over 35 experts from mul-
tiple disciplines concluded that clean birth kits are to be
recommended as long as they do not act as a disincen-
tive for facility birth [94]. The concept of a clean birth
kit has been promoted for many years, and clean birth
kits have been shown to be acceptable in several popula-
tions and may be important in areas where commodities
are the key constraint [58,59,96]. In study settings, clean
birth kits changed behaviours directly related to the
physical components of the kits [58,95], but not to more
distal newborn practices depicted in the accompanying
education leaflet (e.g. immediate breast feeding and
wrapping of the newborn) [58]. Many families and
healthcare workers are not aware of the benefits of
clean practices for newborns and often coverage of
these practices is low [24,27,28,96-99] and influenced by
local culture, especially for cord care [22-24]. Commu-
nity education and birth attendant training are both
associated with a change in practice to cutting the cord
with a clean blade and tying the cord with a clean tie
[23,99]. Few countries have national data regarding cov-
erage of clean birth kits from DHS, and only Nepal has
comparable population level trend data [100]. Despite
fairly extensive social marketing, clean birth kit use
remains low (18% in 2006). Social marketing of insecti-
cide treated bed nets for malaria in very low income
communities may lead to only moderate coverage bene-
fits, compared to free provision. Some evidence suggests
that the role of a clean birth kit may be less important
in communities that already have relatively high use of
clean blade and hand washing[58]. Clean birth kits
could be adapted to include additional components, but
the benefit of adding any additional items must be
weighed up against the increased cost and the appropri-
ate use and effectiveness of these items. A recent analy-
sis suggested that locally made clean birth kits linked
with programs to improve clean practices are highly
cost effective with an estimated US$215 per neonatal
life saved [94]. The added benefit and cost of clean birth
kit promotion compared to behaviour change strategies
alone requires more analysis and evaluation.
Conclusion
While clean birth and postnatal care is widely accepted,
there is understandably low-quality evidence for the
effect of these interventions especially in low income
settings. However, since there is strong biological
plausibility and given that clean practices are an
accepted standard of care, the GRADE recommendation
is strong. Our Delphi expert consensus process judged
that clean birth practices at home with no skilled atten-
dant could reduce neonatal sepsis deaths by 15% and
tetanus deaths by 30%. The panel judged that clean
birth practices in a facility would reduce neonatal deaths
from sepsis by 27% and tetanus by 38%. Postnatal new-
born care practices were considered to have a higher
effect on neonatal mortality with 40% reduction in both
sepsis and tetanus deaths.
More research is needed particularly on the content
and quality of care during the early postnatal period.
Given that most evidence to date is from South Asia,
the results of ongoing studies in Africa are of especial
importance. Use of standard definitions and outcome
case definitions would improve future attempts at evi-
dence synthesis. In addition population-based coverage
data are lacking for clean birth practices or for use of
clean birth kits.
Clean practices at birth and in the postnatal period
could prevent many needless deaths, especially in set-
tings with high baseline neonatal mortality and where
the majority of births still take place at home, although
in many facilities in low income settings, hygienic prac-
tices may also be sub optimal. The benefits of a clean
birth have been recognised for centuries and if this
basic and feasible action was achieved for every mother
and baby of the 135 million births each year, over
100,000 lives could be saved each year [94].
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